DCF — CRESTWOOD MEDICAL CENTER
Enterprise Value: $344.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$344.8M
Enterprise Value
$95.1M
PV of Cash Flows
$249.7M
PV of Terminal Value
$402.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $266.7M | $40.4M | 15.0% | $20.6M | $18.8M |
| Year 2 | $274.7M | $44.3M | 16.0% | $23.3M | $19.3M |
| Year 3 | $282.9M | $48.5M | 17.0% | $26.1M | $19.6M |
| Year 4 | $291.4M | $51.4M | 18.0% | $28.0M | $19.1M |
| Year 5 | $300.2M | $53.7M | 18.0% | $29.4M | $18.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $344.8M. Terminal value accounts for 72% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$258.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.14632090261257893
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5